協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/07/22 | 1,930 | 1,950 | 1,875 | 1,903 | -25 | -1.3% | 1,214,100 |
2016/07/21 | 1,941 | 1,950 | 1,914 | 1,928 | +2 | +0.1% | 1,501,700 |
2016/07/20 | 1,891 | 1,936 | 1,891 | 1,926 | +42 | +2.2% | 2,220,200 |
2016/07/19 | 1,808 | 1,889 | 1,786 | 1,884 | +99 | +5.5% | 2,089,200 |
2016/07/15 | 1,822 | 1,829 | 1,781 | 1,785 | -30 | -1.7% | 953,600 |
2016/07/14 | 1,764 | 1,820 | 1,755 | 1,815 | +50 | +2.8% | 1,113,000 |
2016/07/13 | 1,839 | 1,843 | 1,750 | 1,765 | -77 | -4.2% | 2,111,900 |
2016/07/12 | 1,850 | 1,871 | 1,837 | 1,842 | +22 | +1.2% | 1,085,800 |
2016/07/11 | 1,807 | 1,836 | 1,807 | 1,820 | +51 | +2.9% | 1,204,000 |
2016/07/08 | 1,841 | 1,841 | 1,761 | 1,769 | -65 | -3.5% | 2,480,600 |
2016/07/07 | 1,850 | 1,852 | 1,814 | 1,834 | +92 | +5.3% | 2,508,300 |
2016/07/06 | 1,712 | 1,745 | 1,705 | 1,742 | +4 | +0.2% | 1,055,400 |
2016/07/05 | 1,738 | 1,743 | 1,724 | 1,738 | -2 | -0.1% | 753,900 |
2016/07/04 | 1,726 | 1,746 | 1,712 | 1,740 | +14 | +0.8% | 976,400 |
2016/07/01 | 1,731 | 1,741 | 1,709 | 1,726 | -10 | -0.6% | 1,590,000 |
2016/06/30 | 1,778 | 1,782 | 1,719 | 1,736 | -39 | -2.2% | 2,012,300 |
2016/06/29 | 1,747 | 1,783 | 1,724 | 1,775 | +72 | +4.2% | 2,102,300 |
2016/06/28 | 1,653 | 1,720 | 1,634 | 1,703 | +9 | +0.5% | 1,248,700 |
2016/06/27 | 1,664 | 1,699 | 1,643 | 1,694 | +81 | +5% | 2,461,400 |
2016/06/24 | 1,759 | 1,765 | 1,590 | 1,613 | -146 | -8.3% | 2,489,300 |
2016/06/23 | 1,785 | 1,788 | 1,747 | 1,759 | -20 | -1.1% | 995,200 |
2016/06/22 | 1,792 | 1,799 | 1,758 | 1,779 | -31 | -1.7% | 1,095,300 |
2016/06/21 | 1,793 | 1,816 | 1,775 | 1,810 | +9 | +0.5% | 1,385,700 |
2016/06/20 | 1,825 | 1,839 | 1,795 | 1,801 | -6 | -0.3% | 1,381,700 |
2016/06/17 | 1,841 | 1,847 | 1,803 | 1,807 | +6 | +0.3% | 2,094,600 |
2016/06/16 | 1,869 | 1,886 | 1,795 | 1,801 | -72 | -3.8% | 1,161,900 |
2016/06/15 | 1,850 | 1,880 | 1,846 | 1,873 | +15 | +0.8% | 1,228,500 |
2016/06/14 | 1,900 | 1,903 | 1,842 | 1,858 | -44 | -2.3% | 1,189,200 |
2016/06/13 | 1,926 | 1,940 | 1,902 | 1,902 | -53 | -2.7% | 927,200 |
2016/06/10 | 1,982 | 1,988 | 1,941 | 1,955 | -11 | -0.6% | 1,782,900 |
2016/06/09 | 1,975 | 1,983 | 1,952 | 1,966 | -24 | -1.2% | 832,300 |
2016/06/08 | 1,959 | 1,990 | 1,947 | 1,990 | +25 | +1.3% | 760,900 |
2016/06/07 | 1,951 | 1,987 | 1,940 | 1,965 | +10 | +0.5% | 1,157,600 |
2016/06/06 | 1,925 | 1,958 | 1,916 | 1,955 | +4 | +0.2% | 1,059,400 |
2016/06/03 | 1,939 | 1,957 | 1,929 | 1,951 | +17 | +0.9% | 933,200 |
2016/06/02 | 1,943 | 1,950 | 1,920 | 1,934 | -40 | -2% | 1,420,000 |
2016/06/01 | 1,997 | 2,011 | 1,966 | 1,974 | -46 | -2.3% | 1,674,100 |
2016/05/31 | 2,055 | 2,055 | 1,997 | 2,020 | -37 | -1.8% | 3,316,000 |
2016/05/30 | 2,029 | 2,057 | 1,988 | 2,057 | +28 | +1.4% | 971,600 |
2016/05/27 | 2,049 | 2,063 | 2,025 | 2,029 | -25 | -1.2% | 788,300 |
2016/05/26 | 2,050 | 2,069 | 2,018 | 2,054 | +12 | +0.6% | 1,361,400 |
2016/05/25 | 2,068 | 2,080 | 2,036 | 2,042 | -5 | -0.2% | 1,065,100 |
2016/05/24 | 2,050 | 2,060 | 2,032 | 2,047 | -8 | -0.4% | 1,297,600 |
2016/05/23 | 2,069 | 2,080 | 2,032 | 2,055 | -15 | -0.7% | 1,042,500 |
2016/05/20 | 2,050 | 2,074 | 2,039 | 2,070 | +37 | +1.8% | 1,508,400 |
2016/05/19 | 2,031 | 2,047 | 2,012 | 2,033 | +2 | +0.1% | 939,100 |
2016/05/18 | 2,003 | 2,047 | 2,001 | 2,031 | +9 | +0.4% | 1,215,000 |
2016/05/17 | 1,995 | 2,025 | 1,976 | 2,022 | +40 | +2% | 1,082,900 |
2016/05/16 | 2,007 | 2,020 | 1,981 | 1,982 | -45 | -2.2% | 969,200 |
2016/05/13 | 1,998 | 2,039 | 1,980 | 2,027 | +39 | +2% | 1,657,100 |
2151~
2200
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム